Company: LIMN
Filing Date: 2025-01-27
Form Type: POS AM
Source: 0001104659-25-006325
Chunk: 538

Company: Liminatus Pharma, Inc.
Filing Date: 2025-01-27
Form: POS AM
Chunk 538
---
2022 Viral Gene As of December 31, 2023 and 2022, the Company has $0.1 million due from Viral Gene included in due from related party in the balance sheets for a short-term loan to Viral Gene and expense paid on behalf of Viral Gene. The Company’s CEO is also the CEO of Viral Gene. The loan does not bear any interest and imputed interest would be immaterial. Note 5. Debt The Company has the following debt outstanding as of December 31, 2023 and 2022 (in thousands):

| ​                                
 ​                                | ​ 
 ​ | ​ 
 ​ | ​                                     
 ​                                     | ​ 
 ​ | ​ 
 ​ | December 31, 
 2023         |   |        |   | ​ | ​ | 2022 |   |        |   | ​ 
 ​ |
|:---------------------------------|:--|:--|:--------------------------------------|:--|:--|:-------------|:--|-------:|:--|:--|:--|:-----|:--|-------:|:--|:--|
| Feelux Bonds                     | ​ | ​ | Short-term debt, net, related parties | ​ | ​ | ​            | $ | 10,000 | ​ | ​ | ​ | ​    | $ | 10,000 | ​ | ​ |
| Car-Tcellkor Loan                | ​ | ​ | Short-term debt, net, related parties | ​ | ​ | ​            | ​ |    800 | ​ | ​ | ​ | ​    | ​ |    800 | ​ | ​ |
| Ewon Loan                        | ​ | ​ | Short-term debt, net, related parties | ​ | ​ | ​            | ​ |  2,000 | ​ | ​ | ​ | ​    | ​ |  5,000 | ​ | ​ |
| Valetudo Loan                    | ​ | ​ | Short-term debt, net, related parties | ​ | ​ | ​            | ​ |    700 | ​ | ​ | ​ | ​    | ​ |    700 | ​ | ​ |
| Valetudo June 2023 Loans         | ​ | ​ | Short-term debt, net, related parties | ​ | ​ | ​            | ​ |    500 | ​ | ​ | ​ | ​    | ​ |      — | ​ | ​ |
| Valetudo July 2023 Loan